These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 16849379)

  • 1. Antimicrobial susceptibility of
    Shevtsov A; Syzdykov M; Kuznetsov A; Shustov A; Shevtsova E; Berdimuratova K; Mukanov K; Ramankulov Y
    Antimicrob Resist Infect Control; 2017; 6():130. PubMed ID: 29299304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of a triple versus a standard double antimicrobial regimen for human brucellosis more efficiently eliminates bacterial DNA load.
    Vrioni G; Bourdakis A; Pappas G; Pitiriga V; Mavrouli M; Pournaras S; Tsakris A
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7541-4. PubMed ID: 25246401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrophobic gentamicin-loaded nanoparticles are effective against Brucella melitensis infection in mice.
    Imbuluzqueta E; Gamazo C; Lana H; Campanero MÁ; Salas D; Gil AG; Elizondo E; Ventosa N; Veciana J; Blanco-Prieto MJ
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3326-33. PubMed ID: 23650167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Brucella melitensis and Brucella abortus aminoglycoside-resistant isolates: a systematic review and meta-analysis.
    Moradkasani S; Goodarzi F; Beig M; Tadi DA; Sholeh M
    Braz J Microbiol; 2024 Mar; 55(1):429-439. PubMed ID: 38228936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-genome sequencing and antimicrobial resistance in Brucella melitensis from a Norwegian perspective.
    Johansen TB; Scheffer L; Jensen VK; Bohlin J; Feruglio SL
    Sci Rep; 2018 Jun; 8(1):8538. PubMed ID: 29867163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nano and microparticle drug delivery systems for the treatment of Brucella infections.
    Razei A; Javanbakht M; Hajizade A; Heiat M; Zhao S; Aghamollaei H; Saadati M; Khafaei M; Asadi M; Cegolon L; Keihan AH
    Biomed Pharmacother; 2023 Dec; 169():115875. PubMed ID: 37979375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case report of acute renal failure caused by anti-brucellosis treatment.
    Miao Y; Li X
    Medicine (Baltimore); 2024 Mar; 103(13):e37560. PubMed ID: 38552041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review and meta-analysis of comparative clinical studies on antibiotic treatment of brucellosis.
    Maduranga S; Valencia BM; Li X; Moallemi S; Rodrigo C
    Sci Rep; 2024 Aug; 14(1):19037. PubMed ID: 39152180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Medium pH on Antibiotic Activity against Syrian Brucella spp. Isolates.
    Al-Mariri A; Safi M
    Iran J Med Sci; 2013 Sep; 38(3):248-54. PubMed ID: 24174696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-delivery of doxycycline and rifampicin using CdTe-labeled poly (lactic-co-glycolic) acid for treatment of Brucella melitensis infection.
    Gohari S; Hosseini SM; Nouri F; Yousefimashouf R; Arabestani MR; Taheri M
    BMC Chem; 2024 May; 18(1):100. PubMed ID: 38750589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant Treatment with Doxycycline and Rifampicin in Balb/c Mice Infected with
    Maldonado-García JL; Alvarez-Herrera S; Pérez-Sánchez G; Becerril-Villanueva E; Pavón L; Tesoro-Cruz E; Girón-Pérez MI; Hurtado-Alvarado G; Damián-Morales G; López-Santiago R; Moreno-Lafont MC
    Pharmaceuticals (Basel); 2024 May; 17(5):. PubMed ID: 38794208
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Mena-Bueno S; Poveda-Urkixo I; Irazoki O; Palacios L; Cava F; Zabalza-Baranguá A; Grilló MJ
    Front Microbiol; 2022; 13():908495. PubMed ID: 35875565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): infection with
    ; More S; Bøtner A; Butterworth A; Calistri P; Depner K; Edwards S; Garin-Bastuji B; Good M; Gortázar Schmidt C; Michel V; Miranda MA; Nielsen SS; Raj M; Sihvonen L; Spoolder H; Stegeman JA; Thulke HH; Velarde A; Willeberg P; Winckler C; Baldinelli F; Broglia A; Verdonck F; Beltrán Beck B; Kohnle L; Morgado J; Bicout D
    EFSA J; 2017 Jul; 15(7):e04889. PubMed ID: 32625554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GFP tagging of Brucella melitensis Rev1 allows the identification of vaccinated sheep.
    Zabalza-Baranguá A; San-Román B; Chacón-Díaz C; de Miguel MJ; Muñoz PM; Iriarte M; Blasco JM; Grilló MJ
    Transbound Emerg Dis; 2019 Jan; 66(1):505-516. PubMed ID: 30375177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Antibacterial Activity of Selected Labiatae (Lamiaceae) Essential Oils against Brucella melitensis.
    Al-Mariri A; Safi M
    Iran J Med Sci; 2013 Mar; 38(1):44-50. PubMed ID: 23645957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What have we learned from brucellosis in the mouse model?
    Grilló MJ; Blasco JM; Gorvel JP; Moriyón I; Moreno E
    Vet Res; 2012 Apr; 43(1):29. PubMed ID: 22500859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro assay for the anti-Brucella activity of medicinal plants against tetracycline-resistant Brucella melitensis.
    Motamedi H; Darabpour E; Gholipour M; Seyyed Nejad SM
    J Zhejiang Univ Sci B; 2010 Jul; 11(7):506-11. PubMed ID: 20593515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of several antibiotic combinations against Brucella melitensis Rev 1 experimental infection in BALB/c mice.
    Grilló MJ; De Miguel MJ; Muñoz PM; Marín CM; Ariza J; Blasco JM
    J Antimicrob Chemother; 2006 Sep; 58(3):622-6. PubMed ID: 16849379
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.